Abstract:Objective: To explore the expression and correlation of microRNA-29a (miR-29a), microRNA-126a-5p (miR-126a-5p) and microRNA-21-3p (miR-21-3p) in severe acute pancreatitis. Methods: A total of 82 patients with acute pancreatitis in our hospital from March 2020 to March 2021 were selected as the observation group, including 43 patients with mild acute pancreatitis, 39 patients with severe acute pancreatitis, and 40 normal physical examinees in the same period were selected as the control group. The expressions of miR-29a, mir-126a-5p and mir-21-3p were detected by real-time fluorescence quantitative method. The severity of patients was evaluated by acute physiology and chronic health assessment (APACHE II) and Ranson scoring system. Pearson correlation was used to analyze the correlation of miR-29a, mir-126a-5p and mir-21-3p. Results: Compared with the control group, the expression levels of miR-29a and miR-21-3p in the observation group increased, and the expression levels of miR-126a-5p decreased, with statistical significance (P<0.05). Compared with patients with mild acute pancreatitis, the expression levels of miR-29a and miR-21-3p reduce in patients with severe acute pancreatitis, and the expression levels of miR-126a-5p rise, with statistical significance (P<0.05). With the exacerbation of severe acute pancreatitis, the expression levels of miR-29a and miR-21-3p increased, and the expression levels of miR-126a-5p decreased, with statistical significance (P<0.05). The results show that the negative phase of miR-29a is related to mir-126a-5p (r=-0.447; P = 0.003); the positive correlation of miR-29a with mir-21-3p (r=0.534; P = 0.001);the negative phase of mir-126a-5p was related to mir-21-3p (r=-0.517; P = 0.001). Conclusion: MiR-29a and miR-21-3p are highly expressed in the serum of patients with severe acute pancreatitis, and miR-126a-5p is low expressed in the serum of patients with severe acute pancreatitis, and abnormal levels of miR-29a, miR-126a-5p and miR-21-3p were risk factors for severe acute pancreatitis. It can be used as an indicator for the detection of severe acute pancreatitis.
张倩倩, 王成立, 伏添, 吕杰. miR-29a miR-126a-5p miR-21-3p在重症急性胰腺炎中的表达及相关性研究[J]. 河北医学, 2021, 27(12): 1991-1995.
ZHANG Qianqian, WANG Chengli, Fu Tian, et al. The Expression and Correlation of MiR-29a MiR-126a-5p and MiR-21-3p in Severe Acute Pancreatitis. HeBei Med, 2021, 27(12): 1991-1995.
[1] 刘云,孙静芳,丁爽.血常规相关指标在急性胰腺炎分期和病情评估中的作用分析[J].检验医学与临床,2021,18(8):1025~1028. [2] 乔芳珍,王晋喜.重症急性胰腺炎围胰腺区域性微创治疗的临床疗效分析[J].中国药物与临床,2019,19(5):825~827. [3] Ma D,Li C,Jiang P,et al.Inhibition of ferroptosis attenuates acute kidney injury in rats with severe acute pancreatitis[J].Dig Dis Sci,2021,66(2):483~492. [4] Gomes CA,Di Saverio S,Sartelli M,et al.Severe acute pancreatitis:eight fundamental steps revised according to the 'PANCREAS' acronym[J].Ann R Coll Surg Engl,2020,102(8):555~559. [5] 中华医学会急诊分会,京津冀急诊急救联盟,北京医学会急诊分会,等.急性胰腺炎急诊诊断及治疗专家共识[J].中华急诊医学杂志,2021,30(2):161~172. [6] Hadi A,Werge M,Kristiansen KT,et al.Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis:case report on three family members[J].Pancreatology,2020,20(4):665~667. [7] 张丽涓,沈钦,陈淘江,等.漂浮导管对重症急性胰腺炎继发脓毒血症患者临床治疗的价值研究[J].四川医学,2021,42(1):10~13. [8] Tian B,Qu D,Sasaki A,et al.Acute pancreatitis in patients with severe fever with thrombocytopenia syndrome virus infection[J].Pancreatology,2020,20(8):1631~1636. [9] Yang AL,McNabb-Baltar J.Hypertriglyceridemia and acute pancreatitis[J].Pancreatology,2020,20(5):795~800. [10] 韩永艳,王春耀,杨林,等.微小RNA-216a、324-5p、29a在急性胰腺炎患者外周血中的表达及其与并发肝损伤的相关性[J].中华医学杂志,2020,100(27):2126~2131. [11] 丁谦谦,楼定进,王海英.miR-216a-5p调控XIAP对急性胰腺炎腺泡细胞增殖、凋亡的影响[J].世界华人消化杂志,2019,27(15):918~926. [12] 崔昭,梁博,李国东,等.炎症性肠病患者血清miR-181a-5p和miR-126表达水平及其与肠道菌群相关性的研究[J].国际消化病杂志,2021,41(1):33~37. [13] 李刚,王学莉.急性胰腺炎患者血清miR-551-5p和miR-126a-5p水平与病情严重程度的相关性[J].内科急危重症杂志,2020,26(3):203~206,215. [14] 龙翔宇,周伟,江波,等.长链非编码RNA FTX靶向miR-21-3p对肝癌细胞生长侵袭和迁移调控作用[J].中华肿瘤防治杂志,2019,26(17):1244~1250. [15] 吴开李,王连臣,符国宏,等.急性胰腺炎患者血浆miR-21-3p和miR-551-5p表达水平及临床意义[J].中华危重病急救医学,2020,32(4):463~467.